Table 1

Subject and disease characteristics (safety population)

Subject characteristicSafety population (N=38)
Age at screening (years)
Mean (SD)52.4 (15.80)
Min, Max22, 77
Sex, n (%)
Male13 (34.2%)
Female25 (65.8%)
Race/Ethnicity, n (%)
White—not Hispanic or Latino26 (68.4%)
Black/African American—not Hispanic or Latino7 (18.4%)
White—Hispanic or Latino5 (13.2%)
Disease characteristic (N=38)Study eye*Fellow eye†
Uveitis type, n (%)
Anterior uveitis12 (31.6%)10 (26.3%)
Intermediate uveitis15 (39.5%)12 (31.6%)
Posterior uveitis10 (26.3%)8 (21.1%)
Panuveitis10 (26.3%)7 (18.4%)
Uveitis onset, n (%)
Sudden16 (42.1%)4 (10.5%)
Insidious20 (52.6%)10 (26.5%)
Uveitis duration, n (%)
Limited (≤3 months duration)5 (13.2%)3 (7.9%)
Persistent (>3 months duration)31 (81.6%)11 (28.9%)
Uveitis course, n (%)
Acute1 (2.6%)1 (2.6%)
Recurrent11 (28.9%)1 (2.6%)
Chronic24 (63.2%)12 (31.6%)
Aetiology of uveitis, n (%)
Idiopathic or not specified21 (55.3%)15 (39.5%)
Sarcoidosis8 (21.1%)8 (21.1%)
HLA-B27 related3 (7.9%)2 (5.3%)
Reactive arthritis2 (5.3%)2 (5.3%)
Vogt-Koyanagi-Harada syndrome1 (2.6%)1 (2.6%)
Birdshot retinochoroidopathy3 (7.9%)3 (7.9%)
  • *Two study eyes were not assessed for disease characteristics.

  • †Thirty-one out of 38 fellow eyes were diagnosed with uveitis.